Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DOD Biotech PCL's Other Operating Expense for the
three
months ended in Mar. 2026 was ฿-2.6 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ฿-12.7 Mil.
DOD Biotech PCL's quarterly Other Operating Expense
increased
from Sep. 2025 (฿-4.8 Mil) to Dec. 2025 (฿-3.1 Mil) and
increased
from Dec. 2025 (฿-3.1 Mil) to Mar. 2026 (฿-2.6 Mil).
DOD Biotech PCL's annual Other Operating Expense
increased
from Dec. 2023 (฿-29.1 Mil) to Dec. 2024 (฿-16.7 Mil) and
increased
from Dec. 2024 (฿-16.7 Mil) to Dec. 2025 (฿-12.2 Mil).
DOD Biotech PCL Other Operating Expense Related Terms
DOD Biotech PCL Other Operating Expense Historical Data
* Premium members only.
The historical data trend for DOD Biotech PCL's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-12.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ฿-12.7 Mil mean?
DOD Biotech PCL (BKK:DOD) has a Other Operating Expense of ฿-12.7 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on DOD Biotech PCL and its competitors.
Is DOD Biotech PCL's Other Operating Expense too high?
DOD Biotech PCL's current Other Operating Expense is ฿-12.7 Mil. Overall, DOD Biotech PCL has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Other Operating Expense compare to KHC and GIS?
DOD Biotech PCL's Other Operating Expense of ฿-12.7 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Consumer Packaged Goods company?
A good Other Operating Expense depends on the Consumer Packaged Goods industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on DOD Biotech PCL and its competitors. DOD Biotech PCL's current Other Operating Expense is ฿-12.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Possible Value Trap. The stock's GF Value™ is ฿1.67, compared to a current price of ฿0.98 — trading 41.3% below its estimated fair value. The current Other Operating Expense is ฿-12.7 Mil. DOD Biotech PCL's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current Other Operating Expense is ฿-12.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?
Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued.
The current stock price of ฿0.98 is trading 41.3% below its estimated GF Value™ of ฿1.67.
GuruFocus considers DOD Biotech PCL to be Possible Value Trap.
Key valuation signals for BKK:DOD:
Other Operating Expense: ฿-12.7 Mil
GF Value™: ฿1.67 vs. price of ฿0.98 (41.3% below fair value)
No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
65GF Score
Get the complete analysis for BKK:DOD
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:DOD has been successfully added to your 
